...
首页> 外文期刊>Eating behaviors >N-acetylcysteine in bulimia nervosa - Open-label trial
【24h】

N-acetylcysteine in bulimia nervosa - Open-label trial

机译:神经性贪食症中的N-乙酰半胱氨酸-开放标签试验

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this 12-week open-label flexible-dose study was to preliminarily assess the effectiveness of N-acetylcysteine (NAC) in bulimia nervosa (BN). The primary outcome was binge-purge episode frequency. Eight individuals with BN by DSM-IV criteria received NAC, but only two completed the study. NAC was not associated with significant reductions in frequency of binge-purge episodes or measures of clinical severity, eating, or mood pathology. In this trial, NAC was ineffective in BN and was associated with a high discontinuation rate. ? 2012 Elsevier Ltd.
机译:这项为期12周的开放标签灵活剂量研究的目的是初步评估N-乙酰半胱氨酸(NAC)在神经性贪食症(BN)中的有效性。主要结果是暴饮发作频率。符合DSM-IV标准的8名BN患者接受了NAC,但只有2名完成了研究。 NAC与暴食发作频率或临床严重程度,饮食或情绪病理学指标的显着降低无关。在该试验中,NAC对BN无效,且停用率高。 ? 2012爱思唯尔有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号